Affiliations 

  • 1 The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia
  • 2 West of Scotland Genetics Service, Southern General Hospital, Glasgow, G51 4TF, UK
  • 3 Genetics Department, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • 4 Genetic Services of Western Australia, Subiaco, WA 6008, Australia
  • 5 Department of Pediatrics and Adolescent Medicine Medical University of Vienna, A-1090 Vienna Waehringerguertel 18-20, Vienna, Austria
  • 6 Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia
  • 7 Discipline of Genetic Medicine, The University of Sydney, Sydney, Australia
Clin Genet, 2015 Dec;88(6):550-7.
PMID: 25492405 DOI: 10.1111/cge.12550

Abstract

Short-rib thoracic dystrophies (SRTDs) are congenital disorders due to defects in primary cilium function. SRTDs are recessively inherited with mutations identified in 14 genes to date (comprising 398 exons). Conventional mutation detection (usually by iterative Sanger sequencing) is inefficient and expensive, and often not undertaken. Whole exome massive parallel sequencing has been used to identify new genes for SRTD (WDR34, WDR60 and IFT172); however, the clinical utility of whole exome sequencing (WES) has not been established. WES was performed in 11 individuals with SRTDs. Compound heterozygous or homozygous mutations were identified in six confirmed SRTD genes in 10 individuals (IFT172, DYNC2H1, TTC21B, WDR60, WDR34 and NEK1), giving overall sensitivity of 90.9%. WES data from 993 unaffected individuals sequenced using similar technology showed two individuals with rare (minor allele frequency <0.005) compound heterozygous variants of unknown significance in SRTD genes (specificity >99%). Costs for consumables, laboratory processing and bioinformatic analysis were

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.